Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichiro Watanabe

Showing results (211-220 of 230) with videos related to

Pageof 23
Sort By:
Psychiatry Research|December 27, 2015
Rare truncating variations and risk of schizophrenia: Whole-exome sequencing in three families with affected siblings and a three-stage follow-up study in a Japanese populationYuichiro Watanabe, Ayako Nunokawa, Masako Shibuya, et al.
Plos One|November 27, 2013
An evaluation of association between a novel hippocampal biology related SNP (rs7294919) and schizophreniaJiewei Liu, Shusuke Numata, Masashi Ikeda, et al.
Journal of Atherosclerosis and Thrombosis|November 1, 2002
The generation of monoclonal antibodies against human peroxisome proliferator-activated receptors (PPARs)Toshiya Tanaka, Tetsu Takeno, Yuichiro Watanabe, et al.
Psychiatry Research|December 16, 2018
Pathological alterations of chondroitin sulfate moiety in postmortem hippocampus of patients with schizophreniaTakayuki Yukawa, Yuriko Iwakura, Nobuyuki Takei, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|November 19, 2011
Association of SNPs linked to increased expression of SLC1A1 with schizophreniaYasue Horiuchi, Syuhei Iida, Minori Koga, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2003
Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndromeToshiya Tanaka, Joji Yamamoto, Satoshi Iwasaki, et al.
Schizophrenia Bulletin|November 18, 2008
Supportive evidence for reduced expression of GNB1L in schizophreniaHiroki Ishiguro, Minori Koga, Yasue Horiuchi, et al.
Human Molecular Genetics|April 14, 2009
Involvement of SMARCA2/BRM in the SWI/SNF chromatin-remodeling complex in schizophreniaMinori Koga, Hiroki Ishiguro, Saori Yazaki, et al.
Molecular Cytogenetics|July 3, 2015
Assessment of copy number variations in the brain genome of schizophrenia patientsMiwako Sakai, Yuichiro Watanabe, Toshiyuki Someya, et al.
Plant & Cell Physiology|December 9, 2015
The Naming of Names: Guidelines for Gene Nomenclature in MarchantiaJohn L Bowman, Takashi Araki, Mario A Arteaga-Vazquez, et al.
Pageof 23

Showing results (211-220 of 230) with videos related to

Sort By:
Pageof 23
Psychiatry Research|December 27, 2015
Rare truncating variations and risk of schizophrenia: Whole-exome sequencing in three families with affected siblings and a three-stage follow-up study in a Japanese populationYuichiro Watanabe, Ayako Nunokawa, Masako Shibuya, et al.
Plos One|November 27, 2013
An evaluation of association between a novel hippocampal biology related SNP (rs7294919) and schizophreniaJiewei Liu, Shusuke Numata, Masashi Ikeda, et al.
Journal of Atherosclerosis and Thrombosis|November 1, 2002
The generation of monoclonal antibodies against human peroxisome proliferator-activated receptors (PPARs)Toshiya Tanaka, Tetsu Takeno, Yuichiro Watanabe, et al.
Psychiatry Research|December 16, 2018
Pathological alterations of chondroitin sulfate moiety in postmortem hippocampus of patients with schizophreniaTakayuki Yukawa, Yuriko Iwakura, Nobuyuki Takei, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|November 19, 2011
Association of SNPs linked to increased expression of SLC1A1 with schizophreniaYasue Horiuchi, Syuhei Iida, Minori Koga, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2003
Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndromeToshiya Tanaka, Joji Yamamoto, Satoshi Iwasaki, et al.
Schizophrenia Bulletin|November 18, 2008
Supportive evidence for reduced expression of GNB1L in schizophreniaHiroki Ishiguro, Minori Koga, Yasue Horiuchi, et al.
Human Molecular Genetics|April 14, 2009
Involvement of SMARCA2/BRM in the SWI/SNF chromatin-remodeling complex in schizophreniaMinori Koga, Hiroki Ishiguro, Saori Yazaki, et al.
Molecular Cytogenetics|July 3, 2015
Assessment of copy number variations in the brain genome of schizophrenia patientsMiwako Sakai, Yuichiro Watanabe, Toshiyuki Someya, et al.
Plant & Cell Physiology|December 9, 2015
The Naming of Names: Guidelines for Gene Nomenclature in MarchantiaJohn L Bowman, Takashi Araki, Mario A Arteaga-Vazquez, et al.
Pageof 23